Current concepts in coronary artery revascularisation

Mario Gaudino1, Felicita Andreotti2, Takeshi Kimura3

  • 1Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.

PubMed

Insights

Coronary revascularisation offers surgical or percutaneous options. While surgery has higher risks, it reduces future cardiac events, though medical therapy may suffice for some patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Coronary artery revascularisation is a key treatment for obstructive coronary artery disease.
  • Surgical revascularisation involves higher procedural risk and longer recovery than percutaneous interventions.
  • Despite benefits in reducing recurrent cardiac events, current data predominantly represent specific demographics and regions.

Purpose of the Study:

  • To review the current landscape of coronary artery revascularisation.
  • To highlight the comparative risks and benefits of surgical versus percutaneous approaches.
  • To identify critical gaps in existing research regarding diverse patient populations and global contexts.

Main Methods:

  • Review of existing literature on coronary artery revascularisation.
  • Comparison of outcomes between surgical and percutaneous interventions.
  • Analysis of patient selection criteria, including clinical, anatomical, and preference-based factors.

Main Results:

  • Surgical revascularisation offers long-term reduction in recurrent cardiac events but carries higher procedural risk and recovery time.
  • Percutaneous interventions present a lower-risk alternative with faster recovery.
  • Medical therapy alone may be a viable option for select patient subsets.
  • Existing research is heavily biased towards White, non-elderly, male populations in high-income countries.

Conclusions:

  • Patient choice, clinical presentation, and anatomical factors guide revascularisation decisions.
  • Medical therapy is an essential component of care and may be sufficient in specific cases.
  • Urgent need exists for comprehensive data on revascularisation outcomes in women, older adults, minorities, and low- to middle-income countries.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
13
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
17
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
38
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
12
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
36
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
18